Residency · Torrance, CA
Sponsored by Los Angeles County-Harbor-UCLA Medical Center
Long-term mortality and extrahepatic outcomes in 1096 children with MASLD: A retrospective cohort study.
Hepatology (Baltimore, Md.) · 2026 · 35 citations · Jeffrey Schwimmer
AASLD Practice Statement on the evaluation and management of metabolic dysfunction-associated steatotic liver disease in children.
Hepatology (Baltimore, Md.) · 2025 · 57 citations · Jeffrey Schwimmer
Project Baby Bear: Rapid precision care incorporating rWGS in 5 California children's hospitals demonstrates improved clinical outcomes and reduced costs of care.
American journal of human genetics · 2021 · 214 citations · Jason Knight
Metabolic dysfunction-associated steatotic liver disease in children.
Gut · 2025 · 44 citations · Jeffrey Schwimmer
Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Child & adolescent health · 2024 · 64 citations · Lynda Polgreen
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.
Nature genetics · 2022 · 181 citations ·
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Lancet (London, England) · 2021 · 165 citations · Sheetal Vora
Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system.
The Lancet. Infectious diseases · 2023 · 118 citations · Bradley Ackerson